Chemed Corporation announced that for full-year 2022 earnings per diluted share, excluding non-cash expense for stock options, tax benefits from stock option exercises, costs related to litigation, retention program for licensed healthcare employees, and other discrete items, is estimated to be in the range of $19.60 to $19.70.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
539.4 USD | -0.73% | -3.50% | -7.90% |
May. 21 | Declaration of Voting Results by Chemed Corporation | CI |
May. 21 | RBC Cuts Price Target on Chemed to $697 From $712, Maintains Outperform Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.90% | 8.2B | |
+20.50% | 83.46B | |
-2.68% | 25.66B | |
+3.31% | 17.91B | |
-15.21% | 16.54B | |
+0.41% | 15.43B | |
+75.26% | 13.46B | |
+74.21% | 12.78B | |
+40.18% | 12.6B | |
+1.03% | 12.55B |
- Stock Market
- Equities
- CHE Stock
- News Chemed Corporation
- Chemed Corporation Provides Earnings Guidance for the Year 2022